KEGG: sew:SeSA_A2556
NuoA functions as an integral membrane subunit of the NADH:quinone oxidoreductase complex (Complex I) in S. schwarzengrund. This complex catalyzes the transfer of electrons from NADH to quinones in the respiratory chain while generating proton motive force across the membrane. The nuoA subunit, specifically, contributes to the membrane-embedded domain of the complex that participates in proton translocation. While studies have extensively characterized other nuo subunits like nuoG, nuoM, and nuoN in Salmonella species, nuoA appears to play a complementary role in maintaining the structural integrity and functional efficiency of the complex .
NuoA expression directly influences the assembly and efficiency of Complex I, which serves as the primary entry point for electrons into the respiratory chain. Research indicates that under aerobic conditions, Salmonella primarily utilizes ubiquinone as the electron carrier, while under anaerobic conditions, it shifts to demethylmenaquinone and menaquinone. The expression of nuoA and other nuo operon genes is typically regulated in response to oxygen availability and energy demands. Increased expression of NADH:quinone oxidoreductase-1 has been observed in ubiquinone-biosynthesis mutant strains, suggesting compensatory mechanisms to maintain electron flow through alternative quinones . In S. schwarzengrund specifically, nuoA expression patterns would be expected to follow similar regulatory patterns as observed in other Salmonella serovars.
Mutations in nuo genes can significantly alter respiratory capabilities in Salmonella. Research on related nuo subunits has demonstrated that specific mutations can enhance electron transfer to alternative quinones when primary pathways are compromised. For instance, mutations in nuoG (Q297K), nuoM (A254S), and nuoN (A444E) have been shown to improve electron flow activity from NADH to demethylmenaquinone or menaquinone in ubiquinone-deficient strains . By analogy, mutations in nuoA might similarly affect the complex's affinity for different quinone types, potentially enhancing respiratory flexibility under different environmental conditions.
The hydrophobic nature of nuoA suggests that mutations in this subunit could specifically alter membrane integration or subunit interactions within the complex. Methodologically, studying such effects would require generating point mutations in nuoA, followed by characterization of quinone utilization profiles using HPLC analysis of membrane extracts and measuring electron transfer rates with different quinone substrates under varied oxygen tensions .
S. schwarzengrund has emerged as the third Salmonella serovar to expand its distribution related to pESI-like plasmid acquisition, following S. Infantis and S. Muenchen . These megaplasmids (~280 kb) carry multiple antimicrobial resistance genes and have been associated with enhanced environmental persistence. The relationship between respiratory chain components like nuoA and plasmid-mediated resistance is complex and bidirectional.
The expression of recombinant nuoA may be affected by the metabolic burden imposed by pESI-like plasmids. Conversely, efficient electron transport supported by properly functioning nuoA could provide the energy required for expressing resistance mechanisms encoded by these plasmids. Research methodologies to investigate this relationship should include transcriptomic analysis comparing nuoA expression levels in plasmid-bearing versus plasmid-free isogenic strains, as well as fitness assays under antimicrobial pressure with controlled nuoA expression levels .
S. schwarzengrund has been detected in broiler chickens and chicken meat, suggesting adaptation to agricultural settings . The persistence of Salmonella in such environments may be influenced by respiratory flexibility mediated by Complex I components including nuoA. Experimental approaches to investigate this would involve comparative survival studies of wild-type versus nuoA-modified strains in soil microcosms, plant colonization assays, and competition experiments.
Methodologically, researchers could use dialysis tube systems to expose recombinant S. schwarzengrund expressing modified nuoA to plant-derived substrates such as lettuce root exudates, followed by transcriptomic analysis to identify adaptive responses . Such experiments should control for environmental variables including temperature, moisture, and competing microbiota while monitoring bacterial populations over extended periods (e.g., 7, 21, 35, and 49 days) to assess long-term persistence .
Expression of recombinant nuoA presents several challenges due to its hydrophobic nature as a membrane protein. Researchers should consider the following methodological approach:
Vector selection: Use low-copy expression vectors with tunable promoters (e.g., arabinose-inducible pBAD or IPTG-inducible pET systems with T7lac promoters)
Host optimization:
E. coli C41(DE3) or C43(DE3) strains are recommended as they are engineered for membrane protein expression
Consider S. Typhimurium LT2 with nuo deletions as an alternative host for homologous expression
Expression conditions:
Induce at lower temperatures (16-20°C) to prevent inclusion body formation
Use lower inducer concentrations for slower expression rates
Supplement with ubiquinone precursors to support proper membrane integration
Solubilization and purification:
Extract membrane fractions using ultracentrifugation
Solubilize with mild detergents like n-dodecyl-β-D-maltoside (DDM) or lauryl maltose neopentyl glycol (LMNG)
Purify using nickel affinity chromatography with His-tagged constructs, followed by size exclusion chromatography
To verify expression and functionality, immunoblotting should be performed using antibodies against epitope tags or the nuoA protein itself, followed by activity assays measuring electron transfer from NADH to various quinone substrates .
For creating precise modifications in nuoA, researchers should employ the following methodological approach:
Mutation design:
Target conserved residues identified through multiple sequence alignments
Focus on residues near quinone-binding sites or proton channels
Consider charge-altering substitutions that might affect proton translocation
Mutagenesis methods:
Use overlap extension PCR for introducing specific mutations
Alternatively, employ CRISPR-Cas9 genome editing with homology-directed repair
For larger modifications, consider lambda Red recombineering
Verification procedures:
Sanger sequencing to confirm the intended mutation
Whole genome sequencing to rule out off-target mutations
RT-qPCR to confirm normal transcription levels
Functional validation:
Measure NADH oxidation rates using membrane vesicles and different quinone substrates
Assess proton pumping efficiency using pH-sensitive fluorescent dyes
Compare growth rates under different respiratory conditions (aerobic, microaerobic, anaerobic)
When analyzing mutant phenotypes, researchers should compare them to both wild-type and complemented strains to ensure that observed effects are specifically due to the nuoA mutations .
To quantify electron transfer mediated by nuoA-containing Complex I in S. schwarzengrund, researchers should implement the following methodological workflow:
Membrane preparation:
Harvest cells in late exponential phase
Disrupt cells using French press or sonication
Isolate membrane vesicles through differential centrifugation
Enzyme activity assays:
Measure NADH oxidation spectrophotometrically at 340 nm
Assess quinone reduction using different quinone substrates (ubiquinone, menaquinone, demethylmenaquinone)
Determine sensitivity to specific inhibitors (e.g., piericidin A, rotenone)
Respiration measurements:
Use oxygen electrode systems to measure oxygen consumption rates
Perform assays with different electron donors and acceptors
Calculate respiratory control ratios
Proton translocation:
Monitor pH changes using ACMA (9-amino-6-chloro-2-methoxyacridine) fluorescence quenching
Determine H⁺/e⁻ ratios using the oxygen pulse method
For comparative analyses, researchers should characterize both wild-type and mutant strains under identical conditions, and use inhibitors specific to Complex I versus alternative NADH dehydrogenases to distinguish nuoA-dependent activities .
When analyzing quinone profiles in nuoA-modified S. schwarzengrund strains, researchers should consider the following analytical framework:
Quinone extraction and analysis protocol:
Extract membrane lipids using chloroform-methanol mixtures
Separate quinones by reversed-phase HPLC
Detect quinones by UV absorbance (275 nm) and electrochemical detection
Quantify relative abundances of different quinone species
Expected patterns and interpretation:
Wild-type S. schwarzengrund typically produces ubiquinone and menaquinone under aerobic conditions
Shifts toward demethylmenaquinone may indicate adaptation to nuoA modifications
Reduced total quinone pool often accompanies respiratory chain perturbations
Comparative analysis table:
| Strain Variant | Ubiquinone | Menaquinone | Demethylmenaquinone | Total Quinone Pool |
|---|---|---|---|---|
| Wild-type | +++++ | +++ | + | 100% |
| nuoA deletion | ++ | ++++ | ++++ | 65-80% |
| nuoA point mutant | ++++ | +++ | ++ | 85-95% |
| Complemented strain | +++++ | +++ | + | 95-100% |
Correlation with phenotypes:
Link quinone profile changes to growth rates, motility, and respiratory efficiency
Consider whether changes represent compensatory mechanisms or direct effects
Analyze gene expression changes in quinone biosynthesis pathways
When analyzing nuoA expression across varying environmental conditions, researchers should implement the following statistical approaches:
Data normalization strategies:
Normalize to multiple reference genes validated for stability under tested conditions
Consider geometric averaging of multiple references (GAPDH, gyrA, rpoD)
Apply global normalization methods for RNA-seq data
Statistical methods for differential expression:
For RT-qPCR: Use paired t-tests or ANOVA with post-hoc tests for multiple comparisons
For RNA-seq: Apply negative binomial models (DESeq2, edgeR)
Calculate fold changes with appropriate confidence intervals
Environmental condition comparisons:
Analyze expression patterns across oxygen tensions (aerobic, microaerobic, anaerobic)
Compare expression in different nutrient availabilities
Examine responses to host-relevant conditions (pH, oxidative stress)
Multivariate analysis:
Perform principal component analysis to identify major sources of variation
Use hierarchical clustering to identify co-regulated genes
Employ gene set enrichment analysis to identify affected pathways
Researchers should be cautious when interpreting expression changes of single genes like nuoA, as respiratory chain components often show coordinated regulation. Validation of RNA-based findings with protein-level analyses (Western blots, mass spectrometry) is strongly recommended .
Distinguishing primary effects of nuoA modifications from secondary adaptations requires comprehensive experimental design and careful data interpretation:
Time-course analyses:
Monitor changes immediately following nuoA modification
Track adaptations over extended culturing periods
Use inducible systems to observe acute responses to nuoA expression changes
Multi-omics integration:
Combine transcriptomics, proteomics, and metabolomics data
Identify rapid changes (likely direct effects) versus delayed responses (adaptations)
Construct metabolic flux models to predict system-wide adjustments
Genetic approaches:
Create double mutants targeting nuoA and potential compensatory pathways
Use suppressor mutation analysis to identify genes that can rescue nuoA defects
Implement CRISPR interference for transient, titratable repression
Phenotypic discrimination matrix:
| Parameter | Direct nuoA Effect | Compensatory Adaptation |
|---|---|---|
| Timing | Immediate (minutes to hours) | Delayed (hours to days) |
| Reversibility | Rapidly reversible upon complementation | Persists after complementation |
| Specificity | Primarily affects respiration | Affects multiple cellular processes |
| Genetic dependency | Strictly dependent on nuoA | May involve multiple genetic factors |
By systematically applying these approaches, researchers can build a comprehensive understanding of how nuoA modifications directly impact S. schwarzengrund physiology versus triggering adaptive responses that may mask or exacerbate primary effects .
Research on recombinant nuoA in S. schwarzengrund holds significant potential for developing novel intervention strategies against this pathogen. The respiratory chain represents a vulnerable target that has been relatively unexplored for antimicrobial development. Future research should focus on:
Structure-based drug design targeting unique features of nuoA
Development of attenuated strains with modified nuoA for potential vaccine candidates
Combination approaches targeting both respiratory function and plasmid-mediated resistance
Environmental control strategies that exploit respiratory chain dependencies to reduce persistence in agricultural settings